South Centre Statement on the extension of the TRIPS waiver for diagnostics and therapeutics for COVID-19

[South Centre] Developing countries should consider options that can be implemented now to deal with IP barriers to expand production and access to COVID-19 therapeutics and diagnostics, while the so far elusive decision on whether to extend a TRIPS waiver to cover these products is taken by WTO.